CDM More than 13.5 million people now take weight-loss injections, and the list of potential side effects is growing. Patients and doctors are seeing an increase in tooth decay and gum disease, and a loss of bone and muscle mass. The drugs are also linked to a higher risk of heart disease, pneumonia and even Alzheimer’s.
Story at a glance:
- More than 13.5 million people are now using GLP-1 injections like Ozempic, up from 450,000 in 2018 — a sharp rise linked to an equally sharp increase in side effects.
- Patients using Ozempic are reporting rapid tooth decay, bleeding gums and dental infections — even in people with no history of oral disease or poor hygiene habits.
- Reduced saliva and increased stomach acid — two known side effects of GLP-1 drugs — set the stage for bacterial overgrowth, acid erosion, bad breath and irreversible enamel loss.
- Weight loss from GLP-1 drugs often includes bone and muscle mass, not just fat — putting users at higher risk for fractures, osteoporosis and long-term structural damage.
- The oral bacteria triggered by Ozempic use, such as Porphyromonas gingivalis, are linked not just to gum disease but to heart disease, pneumonia and even Alzheimer’s.
Over 13.5 million people today are now taking GLP-1 drugs — an astounding surge from nearly 450,000 prescriptions in 2018. Once prescribed as a drug for managing Type 2 diabetes, these injections are now being used for weight loss, and sold under brand names like Ozempic, Wegovy and Mounjaro.
It seems like there’s no stopping their popularity. Unfortunately, the same can be said for the side effects being linked to these drugs. Social media is now abuzz with the latest concern being linked to GLP-1 medications. Apparently, people who are using these drugs are now coming down with sudden dental issues.
…
Read Full Article Here…(cdm.press)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
Be First to Comment